Diarrhoea on Mounjaro: Why It Happens and How to Manage It

Diarrhoea on Mounjaro is one of the most frequently reported side effects during the early weeks of treatment. If you have recently started tirzepatide or moved up to a higher dose, loose or watery stools can feel unsettling. However, in most cases the symptom is temporary, manageable, and not a reason to stop treatment.

In this guide, we explain why Mounjaro causes diarrhoea, how long it typically lasts, and what you can do to reduce discomfort while your body adjusts. All advice is drawn from published clinical trial data and the UK prescribing information for tirzepatide.

Yes. Diarrhoea is listed as a “very common” side effect in the MHRA Summary of Product Characteristics for tirzepatide, meaning it affects more than 1 in 10 people during treatment. In the SURMOUNT clinical programme, diarrhoea was the second most common gastrointestinal side effect after nausea. For most patients, episodes are mild to moderate, occur during the dose-escalation phase, and resolve within a few weeks without any change in treatment.

Tirzepatide is a dual GIP and GLP-1 receptor agonist. Both of these hormones influence the speed at which your stomach empties and the way your intestines handle fluid and nutrients. As your body adjusts to the medication, the altered signalling can temporarily disrupt normal bowel patterns.

Furthermore, GLP-1 receptor activation increases fluid secretion into the small intestine. When the volume of fluid reaching the large bowel exceeds its ability to reabsorb water, the result is looser, more frequent stools. This mechanism is well documented across the GLP-1 receptor agonist class and is not unique to Mounjaro.

In addition, changes in appetite and eating habits can contribute. Many patients eat smaller portions or shift their diet substantially during the first weeks of treatment. A sudden increase in fruit, vegetables, or sugar-free products (which often contain sorbitol or other polyols) can loosen stools independently of the medication itself.

Across the four SURMOUNT trials, diarrhoea was reported by approximately 17 to 23 per cent of participants receiving tirzepatide, compared with 7 to 10 per cent of those on placebo. The incidence was dose-related: patients on the 15 mg maintenance dose were more likely to experience diarrhoea than those on 5 mg.

Importantly, the vast majority of episodes were classified as mild (Grade 1) or moderate (Grade 2) in severity. Fewer than 2 per cent of participants across all SURMOUNT trials discontinued tirzepatide because of diarrhoea. In clinical practice at CutKilo, we find that gradual dose escalation and dietary guidance reduce the frequency and severity significantly compared with the trial averages.

For context, diarrhoea rates with tirzepatide are broadly similar to those seen with semaglutide (Ozempic and Wegovy). If you are considering switching from Ozempic to Mounjaro, you should not expect a dramatically different gastrointestinal experience.

Diarrhoea most commonly appears during the first two to four weeks after initiating treatment or after a dose increase. The SURMOUNT trial data show that the majority of gastrointestinal adverse events, including diarrhoea, peaked during the dose-escalation period and declined steadily once a stable maintenance dose was reached.

As a result, most patients find that loose stools settle within two to six weeks. A smaller number of patients experience intermittent, mild episodes that continue for several months but do not interfere meaningfully with daily life. Persistent, severe diarrhoea lasting beyond six weeks is uncommon and warrants a medical review.

Of course, individual variation is significant. Patients who escalate their dose more slowly tend to report fewer and milder gastrointestinal symptoms overall. This is one reason why CutKilo uses a personalised, doctor-led dose-escalation schedule rather than a rigid one-size-fits-all protocol.

There are several practical strategies that can help you manage diarrhoea while continuing your treatment safely.

Stay well hydrated. Loose stools increase fluid and electrolyte losses. Aim for at least two litres of water per day, and consider an oral rehydration solution if episodes are frequent. Avoid relying solely on caffeinated drinks, as these can worsen bowel motility.

Adjust your diet temporarily. During active episodes, favour bland, low-residue foods such as plain rice, toast, bananas, and boiled potatoes. Reduce your intake of high-fat, greasy, or heavily spiced meals, which can aggravate symptoms. Similarly, limit artificial sweeteners, sugar-free chewing gum, and large servings of raw vegetables until your bowel settles.

Eat smaller, more frequent meals. Large meals place greater demand on your digestive system. Spreading your intake across four to five smaller meals can reduce the volume of food reaching your intestines at any one time, which in turn lowers the risk of triggering diarrhoea.

Additionally, consider the timing of your injection. Some patients find that injecting in the evening rather than the morning helps, as the initial peak effect occurs overnight when they are less active. Discuss timing adjustments with your prescribing doctor before making changes.

Avoid abrupt dietary changes. Starting Mounjaro is not the ideal moment to simultaneously overhaul your entire diet. Introduce high-fibre foods gradually rather than all at once. A sudden jump from a low-fibre to a high-fibre diet is a common cause of diarrhoea that is often mistakenly attributed to the medication.

If you are also experiencing nausea alongside diarrhoea, you may find our guide on how to manage nausea on Mounjaro with food helpful, as many of the dietary principles overlap.

In most cases, diarrhoea on Mounjaro is self-limiting and does not require medical intervention beyond the dietary measures described above. Nevertheless, you should contact your prescribing doctor promptly if you experience any of the following:

• Diarrhoea lasting more than 72 hours without improvement
• Signs of dehydration such as dark urine, dizziness, or a dry mouth
• Blood or mucus in your stools
• Severe abdominal pain or cramping
• A fever above 38 degrees Celsius alongside loose stools
• Inability to keep fluids down due to concurrent vomiting

Your doctor may recommend a temporary dose hold or a return to the previous dose level. In rare cases, an alternative cause of diarrhoea (such as a gastrointestinal infection, coeliac disease, or medication interaction) may need to be investigated. Specifically, patients taking metformin alongside Mounjaro should be aware that both medications can cause diarrhoea independently, and the combination may amplify the effect.

Diarrhoea is a common and usually temporary side effect of Mounjaro that affects roughly one in five patients during the dose-escalation phase. The single most important thing to know is that it almost always improves as your body adapts to the medication, and fewer than 2 per cent of patients in clinical trials stopped treatment because of it.

Staying hydrated, eating bland foods during active episodes, and escalating your dose gradually under medical supervision are the most effective ways to manage symptoms. If diarrhoea is severe, persistent, or accompanied by warning signs, contact your prescribing doctor for a review.

Is diarrhoea on Mounjaro dangerous? For the vast majority of patients, no. Most episodes are mild to moderate and resolve on their own. The main risk is dehydration, which can be prevented by drinking plenty of fluids. Contact your doctor if symptoms are severe or persistent.

Will diarrhoea go away as I continue treatment? Yes, in most cases. Clinical trial data from the SURMOUNT programme show that gastrointestinal side effects, including diarrhoea, peak during dose escalation and decline once a stable dose is reached. Most patients see significant improvement within two to six weeks.

Should I take anti-diarrhoeal medication such as loperamide? Over-the-counter loperamide (Imodium) can be used for occasional relief, but you should speak to your doctor before using it regularly alongside Mounjaro. In some cases, slowing gut motility pharmacologically may worsen other symptoms such as nausea or constipation.

Can I prevent diarrhoea by starting on a lower dose? Gradual dose escalation is one of the most effective strategies for reducing gastrointestinal side effects. At CutKilo, your doctor tailors your dose-escalation schedule to your individual response, which helps minimise the risk of diarrhoea compared with a fixed schedule.

Does diarrhoea mean Mounjaro is not working for me? No. Gastrointestinal side effects are a known consequence of GLP-1 receptor agonism and are not a sign that the medication is ineffective. In fact, the presence of GI symptoms during dose escalation often reflects that the medication is pharmacologically active. Weight loss outcomes in clinical trials were not lower among patients who experienced diarrhoea.